Adient (NYSE:ADNT) Issues Earnings Results

Adient (NYSE:ADNT) issued its quarterly earnings data on Wednesday. The company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.16, Briefing.com reports. Adient had a positive return on equity of 7.81% and a negative net margin of 1.93%.The business’s revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the business posted $0.27 EPS.

Here are the key takeaways from Adient’s conference call:

• Adient raised its fiscal 2026 guidance, now targeting approximately $14.6B in sales, about $880M in adjusted EBITDA, and $125M in free cash flow (up from prior guides of $14.4B, $845M, and $90M).
• The company says its onshoring and conquest pipeline has grown to an estimated $500M of incremental revenue (roughly $300M impacting FY2027 and the full $500M in FY2028) and expects a near-term decision from a domestic OEM that could fill much of the remaining opportunity.
• Adient highlighted its new modular manufacturing solution, Modutec, which management says can deliver roughly 20% total value-chain savings, ~15% reduction in JIT floor space, higher automation potential and sustained margin expansion.
• Q1 results showed revenue up 4% YoY and adjusted EBITDA of $207M (5.7%), adjusted net income of $28M ($0.35/sh), $15M free cash flow, $855M cash on hand and $25M of share repurchases, while GAAP reported a $22M loss driven by a one‑time non-U.S. tax settlement.
• Europe remains a drag—management cited continued volume pressure, Chinese imports and elevated restructuring spend (~$120–$130M in FY2026) with future actions and timing dependent on customer program decisions, and APAC faces near-term margin pressure from higher engineering and launch costs.

Adient Price Performance

NYSE:ADNT traded up $3.04 on Wednesday, hitting $24.10. The company had a trading volume of 423,272 shares, compared to its average volume of 1,252,671. Adient has a 52 week low of $10.04 and a 52 week high of $26.16. The firm has a 50 day moving average of $20.11 and a two-hundred day moving average of $21.99. The company has a current ratio of 1.12, a quick ratio of 0.93 and a debt-to-equity ratio of 1.16. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of -7.26, a PEG ratio of 0.51 and a beta of 1.61.

Insiders Place Their Bets

In other Adient news, EVP Michel Pierre Rose Berthelin sold 2,500 shares of the stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $19.71, for a total transaction of $49,275.00. Following the sale, the executive vice president directly owned 116,425 shares in the company, valued at approximately $2,294,736.75. This trade represents a 2.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.94% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ADNT. Glenmede Investment Management LP purchased a new position in shares of Adient during the 3rd quarter worth about $218,000. Envestnet Asset Management Inc. bought a new position in shares of Adient during the third quarter valued at approximately $278,000. Corient Private Wealth LLC purchased a new stake in shares of Adient in the second quarter worth approximately $325,000. Nebula Research & Development LLC bought a new stake in shares of Adient during the 2nd quarter worth approximately $258,000. Finally, Amundi purchased a new position in Adient during the 2nd quarter valued at $269,000. Hedge funds and other institutional investors own 92.44% of the company’s stock.

Analyst Upgrades and Downgrades

ADNT has been the topic of a number of analyst reports. JPMorgan Chase & Co. cut their price target on Adient from $26.00 to $24.00 and set a “neutral” rating on the stock in a research note on Thursday, November 6th. Morgan Stanley upgraded shares of Adient from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $17.00 to $20.00 in a research report on Monday, December 8th. Wells Fargo & Company upped their target price on shares of Adient from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, January 12th. UBS Group set a $30.00 price target on shares of Adient and gave the company a “buy” rating in a report on Wednesday, January 14th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Adient in a report on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $24.56.

About Adient

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.